On April 21st, the world-famous academic publisher Springer released a news report that Tumor Biology, a journal under its rule, retracted 107 articles for authors to prepare reviewers and reviewers. paper. From the list provided by Springer, the authors involved are from China, and there are many famous schools such as Shanghai Jiaotong University, Zhejiang University, and China Medical University. The retraction incident has made the country and the country feel awkward. We have also heard different opinions from all sides. What kind of academic corruption is behind this fraudulent turmoil? In addition, what are the hot spots in the medical industry in the near future? The editor of OFweek Medical Network will take you to review it.
News review
A big scandal in Chinese academic circles: 524 Chinese doctors’ papers were publicly listed
Recently, the famous publisher Springer has decided to withdraw 107 papers from the journal Cancer Biology. These papers were published between 2012 and 2016, all from Chinese scholars.
We are well aware of the low cost of paper fraud in China. Even if a Chinese scholar is found to be fraudulent, he may face only the punishment of “recovering research funds.†In Europe, Japan, and South Korea, counterfeiters may be jailed for fraud, misappropriation of public funds, and cancelled professorships and degrees. . [ Original reading ]
BD Medical's $24 billion acquisition of Bard Technology: a rush into the global medical equipment TOP5
Beijing April 24, BD Medical (Becton Dickinson), announced a $ 24 billion acquisition of supplies medical technology giant Budd Company (CR Bard), plus after the merger of its total sales of $ 13.371 billion. The transaction has been approved by the board of directors of both companies. BD Medical will pay approximately $222.93 in cash per share of Bard's shares, plus 0.5077 shares of BD stock, which is equivalent to $317 per share based on last Friday's closing price.
According to the sales rankings of the world's newest medical device top 100 companies, when the ninth ranked BD medical team and the 24th Bard fit together, its sales may exceed Roche, Philips and Kantler before the global rush into the world. Five, second only to Medtronic, Johnson & Johnson, GE and Siemens. [ Original reading ]
7 Chinese youths selected for the 2017 Forbes Outstanding Medical List
In recent days, Forbes official website announced the age of 30 Asian elite list of the year 2017 "Forbes 30 Under 30 Asia", which is since 2016 the establishment of the list of the second period. These ten areas include art, manufacturing and energy, sports and entertainment, consumer technology, finance and investment, corporate technology, markets and media, healthcare and research, charitable entrepreneurship, and retail and e-commerce.
According to Alan Griffin, Managing Director of Forbes Asia, the release of "Forbes 30 Under 30 Asia" is unprecedented. In 2017, there were 7 outstanding young people from China in the medical research field, including the patent inventor of the genetic editing tool CRISPR, the surgeon of Shenzhen Second People's Hospital, and the outstanding representative in the field of artificial intelligence. [ Original reading ]
197 medical companies changed their names: China Resources and Kyushu have a strong layout
Recently, the author inquired about the procurement platform of local medicines and found that in the first four months of 2017, 11 provinces and cities such as Jiangsu, Hebei, Zhejiang, and Shaanxi issued the Notice of Change of Enterprise Name, and a total of 197 pharmaceutical production and operation enterprises occurred. The name was changed, including 278 production enterprises and 28 business enterprises. The information that has been repeatedly released was deleted, and a total of 197 enterprises were officially renamed.
Among the 197 renaming information, some companies have not changed much, but the company has become a joint-stock company, and some of them have changed their names. Among them, there are industrial layouts of large-scale drug dealers such as Sinopharm, Shanghai Pharmaceutical, China Resources, and Jiuzhoutong, as well as pharmaceutical companies such as Eisai, Shijiazhuang and Renfu Pharmaceutical. [ Original reading ]
Pain Relief Patch For Neck Shoulder,Lower Back And Leg
Pain Relief Patch for neck shoulder, lower back and leg.
[Name] Medical Cold Patch
[Package Dimension] 10cm×12cm 2pieces/box
The pain relief patch is composed of three layers, namely, backing lining, middle gel and protective film. It is free from pharmacological, immunological or metabolic ingredients.
[Scope of Application] For cold physiotherapy, closed soft tissue only.
[Indications]
The patches give fast acting pain relief for strains, sprains, cramp, bruises, swollen areas or joint stiffness.
[How To Use a Patch]
Tear off the packaging bag and remove the patch. Remove the protective film and apply the patch on the skin. One piece, one time. The curing effect of each piece can last for 8-12 hours.
[Attention]
Do not apply the patch on the problematic skin, such as wounds, eczema, dermatitis,or in the eyes. People allergic to herbs and the pregnant are advised not to use the medication. If swelling or irritation occurs, please stop using and if any of these effects persist or worsen.notify your doctor or pharmacist promptly. Children using the patch must be supervised by adults.
[Storage Conditions]
Store below 30c in a dry place away from heat and direct sunlight.
Pain Relief Patch,Pain Relief Pad,Pain Relief Plaster,Neck Pain Relief Patch,Back Pain Relief Pacth
Shandong XiJieYiTong International Trade Co.,Ltd. , https://www.xjplaster.com